Translational Development...

NASDAQ: TDAC · Real-Time Price · USD
10.32
0.00 (0.00%)
At close: Aug 15, 2025, 10:41 AM

Translational Development Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
438.17K 2.02K 2.23K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
174.35M n/a 383.01K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
n/a n/a n/a
Total Current Assets
650.23K 2.02K 54.23K
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
174.35M n/a 383.01K
Total Assets
175M 2.02K 437.24K
Account Payables
16.19K n/a n/a
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a 347.5K 259K
Other Current Liabilities
192.11K n/a n/a
Total Current Liabilities
210.3K 509.68K 459.39K
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
6.04M n/a -50
Total Long-Term Liabilities
6.04M n/a -50
Total Liabilities
6.25M 509.68K 459.34K
Total Debt
n/a 347.5K 259K
Common Stock
18.33B 466.00 466.00
Retained Earnings
-5.6M -532.66K -47.11K
Comprehensive Income
16.88B n/a n/a
Shareholders Equity
168.75M -507.66K -22.11K
Total Investments
174.35M n/a n/a